Skip to content

Effectiveness of Closed Loop Stimulation (CLS) With His Bundle Lead Placement

Effectiveness of Closed Loop Stimulation (CLS) With His Bundle Lead Placement

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03601754
Enrollment
5
Registered
2018-07-26
Start date
2018-07-19
Completion date
2019-01-31
Last updated
2019-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sinus Node Dysfunction

Brief summary

This study is a prospective, non-randomized pilot study looking to evaluate the effectiveness of Closed Loop Stimulation (CLS) in sinus node dysfunction patients with HIS bundle placement. Patients with sinus node dysfunction who have previously received a Biotronik pacemaker with His bundle lead placement as part of routine care will be recruited for the study. A hand-grip exercise will be performed at the conclusion of bicycle exercise testing in order to assess the performance of CLS during isometric exercise. After the study exercise testing is completed, data will be collected from the pacemaker.

Interventions

DIAGNOSTIC_TESTTreadmill/Bicycle exercise testing

Exercise testing will be scheduled on the same day as the enrollment visit and within 30 days after post-implant visit. The standard protocol will be typically set at an initial workload of 15Watts and go up by increments of 10 Watts every 3 minutes, as follows: Stage 1 - 15 W Stage 2 - 25 W Stage 3 - 35 W Stage 4 - 45 W

Sponsors

NYU Langone Health
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* Documented sinus node dysfunction * Biotronik pacemaker implanted with His bundle lead placement for standard indications * Implanted at least 30 days * CLS has been enabled for at least 7 days or will be programmed ON for at least 7 days prior to exercise test * Leads and device are functioning appropriately

Exclusion criteria

* Inability to complete treadmill/bicycle exercise test * Planned surgical revision or replacement of the device and/or leads * Patients who are unwilling or unable to provide informed consent

Design outcomes

Primary

MeasureTime frameDescription
Change in heart rate from baseline to Day 30Day 1, Day 30Ability to achieve adequate heart rate, defined as reaching upper sensor rate, during peak exertion

Secondary

MeasureTime frameDescription
Greater heart response with CLS compared to predicted accelerometer based heart rate responseDay 1, Day 30CLS rate response will be analyzed individually for each subject by comparing the CLS response, which is collected by the CLS Action Log, to heart rate information.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026